135 related articles for article (PubMed ID: 35482249)
1. High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer.
Wang Y; Dong X
Adv Ther; 2022 Jun; 39(6):2946-2960. PubMed ID: 35482249
[TBL] [Abstract][Full Text] [Related]
2. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
Liu R; Wang G; Zhang C; Bai D
World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
[TBL] [Abstract][Full Text] [Related]
3. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
6. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
7. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
8. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
9. Increased expression of
Zheng H; Guo X; Li N; Qin L; Li X; Lou G
Front Genet; 2022; 13():922401. PubMed ID: 36159998
[TBL] [Abstract][Full Text] [Related]
10. C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing lncRNA DUSP5P1 and Associates with Patient Outcomes.
Wang X; Liang Q; Zhang L; Gou H; Li Z; Chen H; Dong Y; Ji J; Yu J
Clin Cancer Res; 2019 May; 25(10):3128-3140. PubMed ID: 30733230
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
12. Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
Zhao Y; Wang W; Li J; Du J; Xie Q; Wang M; Liu Z; Huo X; Zhao F; Ren D; Zhao J; Shen G
PLoS One; 2023; 18(11):e0263710. PubMed ID: 38032902
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
14. PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer.
Wang Z; Dong H; Li W; Han F; Zhao L
J Cancer; 2023; 14(6):1049-1061. PubMed ID: 37151397
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
Zhong G; Lou W; Shen Q; Yu K; Zheng Y
Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
[TBL] [Abstract][Full Text] [Related]
16. KDF1 Promoted Proliferation and Metastasis of Epithelial Ovarian Cancer
Zhu C; Liu Y; Tong R; Guan J
Front Genet; 2022; 13():808100. PubMed ID: 35281796
[No Abstract] [Full Text] [Related]
17. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
[TBL] [Abstract][Full Text] [Related]
18. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
19. Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.
Sun G; Wang T; Shi M; Zhou H; Wang J; Huang Z; Zhang H; Shi J
Ann Transl Med; 2021 Jul; 9(13):1057. PubMed ID: 34422969
[TBL] [Abstract][Full Text] [Related]
20. Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles Analysis.
Li M; Wang K; Pang Y; Zhang H; Peng H; Shi Q; Zhang Z; Cui X; Li F
Med Sci Monit; 2020 Mar; 26():e920355. PubMed ID: 32208405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]